BioCentury
ARTICLE | Company News

Cengent, Dynamis screening deal

November 15, 2004 8:00 AM UTC

Cengent (San Diego, Calif.) will use its Genes to Leads lead identification technology to screen candidates against a target from Dynamis (Elkins Park, Penn.). The target is an enzyme that causes the ...